June 14, 2010 6:05 AM CT By Christine Welniak Atrial fibrillation is a progressive disease that can become more severe over time as AF “remodels” the heart. This results in multiple areas in the atrium that could become “triggers” for AF, areas where afib is initiated or can “re-enter” to cycle throughout the heart. The pulmonary …
Read More
June 8, 2010 7:10 AM CT The Washington Post just did a feature highlighting atrial fibrillation, including treatments and evidence of results. It also included a poignant look at what afib does to patients. Mellanie True Hills, founder of StopAfib.org, was one of three afib patients featured in this article. This article was written by the …
Read More
June 10, 2010 7:05 AM CT By Peggy Noonan and Mellanie True Hills Findings presented at Heart Rhythm 2010, the 31st Annual Scientific Sessions of the Heart Rhythm Society in Denver, Colorado, showed that catheter ablation treatment for atrial fibrillation could reduce the risk of developing Alzheimer’s disease and other dementias and reduce the risk …
Read More
June 7, 2010 8:07 AM CT StopAfib.org is pleased to participate in, and raise awareness of, World Heart Rhythm Week June 7-13, 2010. World Heart Rhythm Week is the annual global event organized by Arrhythmia Alliance (A-A) and held in partnership with ICPES (International Cardiac Pacing and Electrophysiology). The week-long event brings international organizations, groups …
Read More
June 4, 2010 12:17 AM CT By Christine Welniak and Mellanie True Hills The Second Worldwide Multicenter Survey on Catheter Ablation showed a catheter ablation success rate of 70% for atrial fibrillation, but that still leaves a significant number of people who continue to have afib even after a procedure. This can be disheartening to patients and …
Read More
June 3, 2010 6:15 AM CT By Christine Welniak and Mellanie True Hills Healthcare providers at Heart Rhythm Society 2010 seemed to be grappling with what constitutes “success” following catheter ablation. Traditionally success has been defined as the absence of atrial fibrillation (AF) episodes and the ability to discontinue antiarrhythmic drugs. That is, success equates …
Read More
June 1, 2010 12:05 AM CT In this video interview, Dr. Nassir Marrouche talked about the exciting research he and his team presented at Heart Rhythm 2010 that allows them to personalize atrial fibrillation (AF) treatment. They do catheter ablations and manage stroke prevention based on the amount of atrial fibrosis and atrial remodeling detected …
Read More
June 1, 2010 5:04 AM CT By Peggy Noonan and Mellanie True Hills At Heart Rhythm 2010, the 31st Annual Scientific Sessions of the Heart Rhythm Society in Denver, Colorado, a session on "Demographic Factors Influencing Atrial Fibrillation Management and Outcomes" included two studies focused on the connection between race and atrial fibrillation risk and …
Read More
June 27, 2010 8:05 AM CT By Christine Welniak and Mellanie True Hills At Heart Rhythm Society 2010, we saw intriguing new research into personalized afib treatment that was presented by Dr. Nassir Marrouche, Executive Director of the Comprehensive Arrhythmia Research and Management (CARMA) Center at the University of Utah Health System, and his CARMA …
Read More
June 7, 2010 12:05 AM CT In this video interview at Boston Atrial Fibrillation Symposium 2010, Dr. Peter Kowey talked about a number of exciting new things in the atrial fibrillation world, including the Cabana clinical trials, the Safari catheter ablation registry, dronedarone as a replacement for amiodarone, atrial selective drugs, and coming replacements for …
Read More